MACY SUN: Open Payments
NPI 1790313047 · OAKLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,317 in 139 payments from 41 companies in 2025. Trend: 2023 $1,641 · 2024 $2,656 · 2025 $3,317
Food & beverage: $3,217Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $389 |
| PFIZER INC. | 11 | $217 |
| Janssen Biotech, Inc. | 9 | $183 |
| Novartis Pharmaceuticals Corporation | 6 | $178 |
| BeOne Medicines USA, Inc. | 6 | $143 |
| Merck Sharp & Dohme LLC | 5 | $139 |
| ABBVIE INC. | 9 | $136 |
| ARRAY BIOPHARMA INC | 8 | $131 |
| Celgene Corporation | 5 | $119 |
| Genentech USA, Inc. | 4 | $111 |
Products named: TAGRISSO, ENHERTU, KEYTRUDA, REBLOZYL, TEVIMBRA, ELREXFIO, RYTELO, BRAFTOVI.
Industry payments across CA — which companies pay providers there.
